Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 33.20180.22-67.21-38.59-

What is the latest EBIT Growth ratio of PIRAMAL PHARMA ?

The latest EBIT Growth ratio of PIRAMAL PHARMA is 33.20 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202533.20
Mar2024180.22
Mar2023-67.21
Mar2022-38.59
Mar2021-

How is EBIT Growth of PIRAMAL PHARMA Trending?

Years EBIT Growth % Change
Mar2025 33.2
-81.58
Mar2024 180.22
Positive
Mar2023 -67.21
Negative
Mar2022 -38.59
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EBIT Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,742.6 Cr -0.4% -9.8% -36.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,708.0 Cr -2.9% -1.8% -2.5% Stock Analytics
DIVIS LABORATORIES ₹171,975.0 Cr 2.1% 0.2% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,619.0 Cr 0.5% 2.2% 11.2% Stock Analytics
CIPLA ₹122,539.0 Cr 0.7% -0.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,741.0 Cr -0.1% 2.5% 2.5% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0.4%

-9.8%

-36.1%

SENSEX

-0.4%

-0.3%

3.9%


You may also like the below Video Courses